1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
642B7BD97B5F008418525830E00675323
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/driving-the-value-of-digital-initiatives-in-medical-affairs?opendocument
18
19opendocument
2044.200.122.214
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Digital Technology » Cross-Functional Digital Transformation

Driving the Value of Digital Initiatives in Medical Affairs: Roles, Patient Engagement, and Resourcing

ID: 5526


Features:

17 Info Graphics

12 Data Graphics

170+ Metrics


Pages/Slides: 40


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Driving the Value of Digital Initiatives in Medical Affairs: Roles, Patient Engagement, and Resourcing"

STUDY OVERVIEW


Medical Affairs is shifting more and more to digital tools to interact with key internal and external stakeholders. Virtual communication, mobile apps, data analytics tools, interactive platforms and medical booths are some examples of how the digital world is playing an evolving role in Medical Affairs. But as pharmaceutical companies increasingly turn to digital tools for Medical Affairs activities, they also need to adjust internally for roles and reporting, resourcing and patient engagement strategies.

Best Practices, LLC undertook this benchmarking research to provide insights into the operational changes within Medical Affairs that come with digitalization, including roles and reporting, digital initiatives for patient engagement, and resourcing. Medical Affairs leaders can use this study to better align their group with the move to digital activities.

This study provides three segments: all participating companies, digitally mature companies and digitally evolving companies.

KEY TOPICS

  • Roles and Reporting in Digital
  • Empowering Patients via Digital Initiatives
  • Digital Resourcing and Critical Trends

KEY METRICS

  • What is your digital maturity level across: digital planning, digital resources, leadership support and capabilities
  • Which Medical Affairs sub-functions are involved with digital initiatives and what role do they play
  • Describe the digital role and activities of your Medical Affairs group
  • What internal groups does Medical Affairs collaborate with to develop and support digital systems/programs
  • How does Medical Affairs collaborate with internal groups to develop and support digital systems/programs
  • Where is your digital patient engagement program in the overall maturity curve
  • Which digital channels does your Medical Affairs function currently use to engage with patients
  • How much annually does your organization allocate for all Medical Affairs related digital programs
  • What percentage of your total Medical Affairs budget is allocated to digital initiatives
  • What are the top digital engagement trends that will most greatly impact the Medical Affairs funciton going forward

SAMPLE KEY FINDINGS

Top 3 Activities of Medical Affairs Groups Lead Digital Initiatives:

  • Medical Strategy: Supporting and incorporating digital concepts into strategic plan, digitizing scientific platforms and publications content, strategizing access to medical information and education
  • Medical Communications: Identifying target audience and generate content, managing multi channel content formation and using digital tools to collect and analyze insights
  • Medical Information: Developing and maintaining medical channels and content, online medical information service via patient portal, building digital platform for medical inquiries

METHODOLOGY

This study engaged 68 participants From 35 Companies with experience in medical affairs digital activities at top pharmaceutical companies.

Industries Profiled:
Pharmaceutical; Health Care; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Biopharmaceutical; Clinical Research; Laboratories; Communications


Companies Profiled:
Novartis; Boehringer Ingelheim; AstraZeneca; Merck; GlaxoSmithKline ; Bayer; Allergan; Abbott; EMD Serono; GE Healthcare; Sanofi; Roche; Pfizer; Shire; Novo Nordisk; MSD; Astellas; Santen; Jazz Pharmaceuticals; Eisai; Sanofi Pasteur; Vifor Pharma; Alkermes; Sanofi Genzyme; Sunovion; ViiV Healthcare; Sage Therapeutics; Seqirus; Incyte; Chiesi; Heron Therapeutics; Ipsen; Ferring Pharmaceuticals; ApotheCom; Indegene

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.